- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
Learn about the different avenues for sharing, submitting and amplifying CTSA Program-related communications by both NCATS and CLIC
Share impactful stories that illustrate how the CTSA Program is successful in improving the translational science process and public health
Keep up-to-date on what is happening in the consortium
The CTRFP is the largest internal grant funding program of the ICTS. Applicants are required to submit proposals for projects that promote the translation of scientific discoveries into improvements in human health. For 2021, awards were considered across three project categories: clinical/translational, community-engaged research, and biostatistics, epidemiology, and research design.
The SARS-CoV-2, the new coronavirus behind the current pandemic, infects humans by binding its surface-exposed spike proteins to ACE2 receptors exposed on the cell membranes. Upon a vaccination or a real infection, it takes several weeks before the immunity develops antibodies that can selectively bind to these spike proteins. Such antibody-labeled viruses are neutralized by the natural killer and
“The only way forward is to control this by vaccination.” — William Powderly, MD, Director, Washington University Institute of Clinical and Translational Sciences
The proverbial saying ‘Necessity is the mother of invention’ is frequently used to explain how great innovations are made during times of urgent need. Never has the need been direr than when the COVID pandemic hit in March 2020 and health care providers were struggling to find treatments for patients fighting this new and deadly disease. It was during this time, ICTS investigator Eric Lenze, MD
One of the most vexing aspects of the COVID-19 pandemic is doctors’ inability to predict which newly hospitalized patients will go on to develop severe disease, including complications that require the insertion of a breathing tube, kidney dialysis or other intensive care. Knowledge of a patient’s age and underlying medical conditions can help predict such outcomes, but there are still surprises
NCATS has provided the FDA with access to the N3C Data Enclave. FDA investigators interested in accessing N3C COVID-19 data must complete appropriate human subjects and NIH security training, review and abide by NCATS technology transfer requirements, and submit a Data Use Request (DUR) detailing their proposed project and use of N3C data. For details on how FDA investigators can access the N3C
It’s hard to imagine what 2020 would have looked like without the arrival of COVID-19. As we begin the new year, millions of people across the world have been directly affected by the virus. That’s why an interdisciplinary team of researchers from across the University of Michigan, including the Institute for Social Research and the Michigan Institute for Clinical & Health Research (MICHR), have
The workshop series delivers accurate and culturally tailored information to help members of the Latinx community protect themselves and their families during the COVID-19 pandemic. BY PAUL KARON — FEBRUARY 01, 2021 The COVID-19 pandemic has caused illness widely throughout the United States, but some communities have been hit disproportionately hard, such as the Latinx community. To help slow the
In a new study, the Evaluation and Continuous Improvement (ECI) team of the Georgia CTSA evaluated publications characterized as Big Splashes with immediate impact and publications with Ripple Effects over time, to understand how Georgia CTSA-supported research is ‘making waves’ that can accelerate translation. Previous systematic evaluations of the Georgia CTSA’s publication portfolio revealed a
Georgia CTSA Clinical Research Centers offer dedicated space, experienced staff, and resources to support research at a competitive cost. We assist investigators of all experience levels from Emory, Georgia Tech, Morehouse School of Medicine, UGA, and Children's Healthcare of Atlanta in serving adult and pediatric patient populations in Georgia. Watch this new video to learn more about how we help